Casrtation-resistant Prostate Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-03-26
Clinical Trial Update: Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating MRI as a measurement tool for the effect of cabozantinib in patients with castration-resistant prostate cancer.